These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4114107)

  • 1. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of clinical chemical determinations of drug concentrations in biological fluids.
    Vessell ES; Passananti GT
    Clin Chem; 1971 Sep; 17(9):851-66. PubMed ID: 4105897
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol Chemother; 1969; 7():1-52. PubMed ID: 4195046
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
    Vesell ES; Passananti GT; Greene FE; Page JG
    Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
    [No Abstract]   [Full Text] [Related]  

  • 5. Polygenic factors controlling drug response.
    Vesell ES
    Med Clin North Am; 1974 Sep; 58(5):951-63. PubMed ID: 4138463
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of drug metabolism in man.
    Vesell ES; Passananti GT
    Drug Metab Dispos; 1973; 1(1):402-10. PubMed ID: 4129869
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic control of dicumarol levels in man.
    Vesell ES; Page JG
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics.
    Vesell ES
    N Engl J Med; 1972 Nov; 287(18):904-9. PubMed ID: 4561668
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in pharmacogenetics.
    Vesell ES
    Prog Med Genet; 1973; 9():291-367. PubMed ID: 4123249
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent progress in pharmacogenetics.
    Vesell ES
    Adv Pharmacol (1962); 1969; 7():1-52. PubMed ID: 4190237
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of drug metabolism in man by allopurinol and nortriptyline.
    Vesell ES; Passananti GT; Greene FE
    N Engl J Med; 1970 Dec; 283(27):1484-8. PubMed ID: 4098480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic causes for the variability of effects and side effects of drugs].
    Roots I
    Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450
    [No Abstract]   [Full Text] [Related]  

  • 15. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
    Burns JJ
    Ann N Y Acad Sci; 1968 Jul; 151(2):959-67. PubMed ID: 4189972
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics: defective enzymes in relation to reactions to drugs.
    La Du BN
    Annu Rev Med; 1972; 23():453-68. PubMed ID: 4118885
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man].
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic drug interactions.
    Nies AS; Shand DG; Branch RA
    Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
    [No Abstract]   [Full Text] [Related]  

  • 19. Interindividual differences in pharmacokinetics in man: clinical importance.
    Sjöqvist F
    Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
    [No Abstract]   [Full Text] [Related]  

  • 20. Impairment of drug metabolism by disulfiram in man.
    Vesell ES; Passananti GT; Lee CH
    Clin Pharmacol Ther; 1971; 12(5):785-92. PubMed ID: 4936142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.